Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
Journal of Medicinal Chemistry|December 30, 2010
Synthesis and molecular modeling of novel tetrahydro-β-carboline derivatives with phosphodiesterase 5 inhibitory and anticancer propertiesHeba A Mohamed, Nancy M R Girgis, Rainer Wilcken, et al.Journal of Medicinal Chemistry|December 22, 2011
Tri- and tetrasubstituted pyrazole derivates: regioisomerism switches activity from p38MAP kinase to important cancer kinasesBassam Abu Thaher, Martina Arnsmann, Frank Totzke, et al.Journal of Medicinal Chemistry|July 24, 2023
Principles and Applications of CF<sub>2</sub>X Moieties as Unconventional Halogen Bond Donors in Medicinal Chemistry, Chemical Biology, and Drug DiscoverySebastian Vaas, Markus O Zimmermann, Dieter Schollmeyer, et al.Bioorganic & Medicinal Chemistry|October 22, 2013
Trisubstituted and tetrasubstituted pyrazolines as a novel class of cell-growth inhibitors in tumor cells with wild type p53Mohammad Abdel-Halim, Adam B Keeton, Evrim Gurpinar, et al.Marine Drugs|August 25, 2022
Discovery of Ircinianin Lactones B and C-Two New Cyclic Sesterterpenes from the Marine Sponge <i>Ircinia wistarii</i>Thomas Majer, Keshab Bhattarai, Jan Straetener, et al.ACS Omega|August 9, 2018
Structural Optimization of a Pyridinylimidazole Scaffold: Shifting the Selectivity from p38α Mitogen-Activated Protein Kinase to c-Jun N-Terminal Kinase 3Francesco Ansideri, Joana T Macedo, Michael Eitel, et al.Archiv Der Pharmazie|August 11, 2025
Design, Synthesis, and Molecular Evaluation of S<sub>N</sub>Ar-Reactive N-(6-Fluoro-3-Nitropyridin-2-yl)Isoquinolin-3-Amines as Covalent USP7 Inhibitors Reveals an Unconventional Binding ModeLarissa N Ernst, Jason Stahlecker, Finn Mier, et al.RSC Medicinal Chemistry|December 23, 2022
Revisiting a challenging p53 binding site: a diversity-optimized HEFLib reveals diverse binding modes in T-p53C-Y220CJason Stahlecker, Theresa Klett, Martin Schwer, et al.Drug Design, Development and Therapy|April 1, 2025
Screening of Covalent Kinase Inhibitors Yields Hits for Cysteine Protease USP7 / HAUSPLarissa N Ernst, Simon J Jaag, Valentin R Wydra, et al.Journal of Medicinal Chemistry|December 29, 2012
Dibenzosuberones as p38 mitogen-activated protein kinase inhibitors with low ATP competitiveness and outstanding whole blood activityStefan Fischer, Heike K Wentsch, Svenja C Mayer-Wrangowski, et al.Pageof 7